Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis

Clinical trial NCT04596293 · COMPLETED

Trial details

NCT number: NCT04596293
Sponsor: Bridge Biotherapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2021-06-11
Primary completion: 2022-05-17
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.